London 2014 Registration Visa Letters Programme Satellite Meetings Glaucoma Day 2014 Exhibition Hotel Booking Virtual Exhibition Star Alliance
london escrs

Course handouts are now available
Click here

Come to London


WATCH to find out why

Site updates:

Programme Updates. Programme Overview and - Video Symposium on Challenging Cases now available.


Search Abstracts by author or title
(results will display both Free Papers & Poster)

The use of the LENTIS Mplus multifocal IOL in patients with macular problems

Poster Details

First Author: J.Moore UK

Co Author(s):    R. Beirne   A. Sharma   C. Moore        

Abstract Details


To compare and contrast the functional value of implantation of an asymmetrical refractive multifocal in individuals with either healthy or age-related macular disease.


Cathedral Eye Clinic, Belfast, United Kingdom


This study compares consecutive individuals who had implantation of a LENTIS Mplus multifocal IOL after phacoemulsification with co-existing age-related macular pathology to those who had no macular pathology. The main outcomes were monocular corrected distance visual acuity (LogMAR), binocular uncorrected near visual acuities (M unit notation) at the habitual reading distance and Quality of Vision (QoV) questionnaire outcomes


Thirty-six eyes from individuals with co-existing disease were included and were compared with 134 eyes from individuals with no macular disease. Postoperative corrected distance visual acuity was significantly higher in both groups after surgery and unaided binocular near vision was excellent for those with macular pathology (mean M=0.6) and those without (mean M=0.5). There was no statistically significant difference in complaints of glare, starbursts or haze in the macular group compared to those without macular pathology after surgery. The mean QoV scores improved significantly postoperatively in both groups.


Individuals with co-existing macular disease had successful outcomes post-operatively, with similar improvements in subjective quality of vision to those with no macular pathology. Asymmetrical multifocal IOLs such as the Mplus appear safe to use in patients with early age related macular degeneration and epiretinal membranes and result in high patient satisfaction. FINANCIAL INTEREST: NONE

Back to Poster listing